Administration of erythropoiesis-stimulating agents in patients undergoing haemodialysis: A time and motion study.
David W JohnsonBruce ClelandJosette ErisTom RaffertyKamal SudJosephine Sau Fan ChowPublished in: Journal of renal care (2017)
Switching from a short-acting to a long-acting ESA in HD units leads to a significant reduction in time costs of health professionals in preparation and administration of ESAs by up to 80%. Practical application: This time and motion study has added further evidence on reduction of human effort by taking advantages of new research development, such as the long acting ESAs.